Potential chemotherapy options in the triple negative subtype of breast cancer.
Altundag
Kadri
K
Harputluoglu
Hakan
H
Aksoy
Sercan
S
Gullu
Ibrahim H
IH
D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D051242:Caveolin 1 / Q000502:physiology; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
D051242:Caveolin 1; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone